Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hypertension, genotype and oral contraceptives.

Pharmacogenomics - 1 Jan 2002

Mulatero Paolo, Morra di Cella Stefania, Veglio Franco

Abstract excerpt

Oral contraceptive-induced hypertension (OCIH) is a well-recognized phenomenon characterized by an increase in blood pressure levels after beginning estroprogestin therapy and a reduction to normal levels within 1 year after suspension of the therapy. The pathophysiology of this condition is still not understood: several lines of evidence indicate a role for a genetic susceptibility to the development of this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Renin-Angiotensin System
Share to Contraceptives, Oral
Share to Drug Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Profiling

Share to Genetic Predisposition to Disease

Share to Hypertension

Share to Oligonucleotide Array Sequence Analysis

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 11966403
DOI: 10.1517/14622416.3.1.57

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hypertension, genotype and oral contraceptives.PMID 11966403Read ↗

Angiotensin-converting enzyme and angiotensinogen gene polymorphisms are non-randomly distributed in oral contraceptive-induced hypertension.Semantic proximity Read ↗

Pharmacogenomics of primary hypertension--the lessons from the past to look toward the future.Semantic proximity Read ↗

Gender-Specific Effect of CYP2C8*3 on the Risk of Essential Hypertension in Bulgarian PatientsSemantic proximity Read ↗

Hypertension, cardiovascular risk and polymorphisms in genes controlling the cytochrome P450 pathway of arachidonic acid: A sex-specific relation?Semantic proximity Read ↗

A Novel Polymorphism of the CYP19 Gene is Associated with Essential Hypertension in China.Semantic proximity Read ↗

Prevalence of hypertension according to phenotype and gender in autosomal-dominant polycystic kidney disease.Semantic proximity Read ↗

Estrogen synthesis genes CYP19A1, HSD3B1, and HSD3B2 in hypertensive disorders of pregnancy.Semantic proximity Read ↗

Association study of aromatase gene (CYP19A1) in essential hypertension.Semantic proximity Read ↗

Polymorphisms in estrogen metabolism and estrogen pathway genes and the risk of miscarriage.Semantic proximity Read ↗

Estrogen receptor beta genetic variants and combined oral contraceptive use as relates to the risk of hypertension in Chinese women.Semantic proximity Read ↗

11β-Hydroxysteroid dehydrogenase type 2 in hypertension: comparison of phenotype and genotype analysis.Semantic proximity Read ↗

Variants of HSD11B2 gene in hypertensive disorders of pregnancy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.